Fundraising Fox
Graziano Seghezzi
InvestorManaging Partner at Sofinnova Partners
Paris, France
Writes $100K – $5M checks · typically $1.5M
Find your path to Graziano
Sign up to see every warm intro you have to Graziano
- Paths you didn't know you had: your email and LinkedIn already hold routes to Graziano. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing Partner at Sofinnova Partners since 2006 and part of the Sofinnova Capital Strategy team, focused on biotech company creation. He has led numerous exits (including Mablink, Corvidia, GlycoVaxyn, and Omthera) and drove the firm's expansion in Italy, founding the BiovelocITA accelerator and the Sofinnova Telethon Fund. He began his VC career at Sofinnova in 2001, worked at Index Ventures (2003-2006), and previously did academic oncology and cardiovascular research at NYU School of Medicine.
Contact· published on Graziano's own website
Invests in
Biotech
Deals · 1
Hookipa PharmaBoard seat
via Sofinnova Partners · filed Feb 2019
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Corvidia TherapeuticsEntheraGlycoEraHotSpot TherapeuticsMission TherapeuticsT-Therapeutics
Investor
AAVantgarde BioAlia TherapeuticsBorea TherapeuticsCorvidiaCorvidia TherapeuticsCrescendo BiologicsEntheraErydelGenespireGlycoEraGlycovaxynHotSpot TherapeuticsInotremLeucid BioMablinkMablink BioscienceMission TherapeuticsOmthera PharmaceuticalsT TherapeuticsTenpoint Therapeutics
Sources: SEC Form D filings · the firm's website · curated public sources.
Colleagues at Sofinnova Partners
Frequently asked questions
- Who is Graziano Seghezzi?
- Managing Partner at Sofinnova Partners since 2006 and part of the Sofinnova Capital Strategy team, focused on biotech company creation. He has led numerous exits (including Mablink, Corvidia, GlycoVaxyn, and Omthera) and drove the firm's expansion in Italy, founding the BiovelocITA accelerator and the Sofinnova Telethon Fund. He began his VC career at Sofinnova in 2001, worked at Index Ventures (2003-2006), and previously did academic oncology and cardiovascular research at NYU School of Medicine.
- Where does Graziano Seghezzi work?
- Graziano Seghezzi is Managing Partner at Sofinnova Partners.
- What does Graziano Seghezzi invest in?
- Graziano Seghezzi invests in Biotech.
- What check size does Graziano Seghezzi write?
- Graziano Seghezzi typically writes checks of $100K – $5M.
- What boards does Graziano Seghezzi sit on?
- Graziano Seghezzi holds tracked board seats at Corvidia Therapeutics, Enthera, GlycoEra, Hookipa Pharma, HotSpot Therapeutics, Mission Therapeutics, T-Therapeutics.
- What companies has Graziano Seghezzi invested in?
- Investments tracked here include AAVantgarde Bio, Alia Therapeutics, Borea Therapeutics, Corvidia, Corvidia Therapeutics, Crescendo Biologics, Enthera, Erydel, Genespire, GlycoEra, Glycovaxyn, Hookipa Pharma, and 9 more.
About this profile. Compiled from public sources — Sofinnova Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights